Market Research Logo

Genomic Vision (GV) - Product Pipeline Analysis, 2018 Update

Summary

Genomic Vision (Genomic) is a molecular diagnostics and technology company that develops and commercializes diagnostic tests for genetic diseases and cancers. The company’s portfolio comprises tests for breast cancer and colon cancer, diagnostic solution for facio-scapulo-humeral muscular dystrophy; and tools for identifying and characterizing rearrangements which affect the BRCA1 and BRCA2 genes. Its diagnostic tests are based on DNA molecular combing technology. Genomic’s technology finds application in monitoring both spatial and temporal characteristics of DNA replication in a single experiment and identification of structural variations at any position within the genome. It conducts research studies on large genomic rearrangements. Genomic is headquartered in Paris, France.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Genomic Vision
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Genomic Vision Company Overview
Genomic Vision Company Snapshot
Genomic Vision Pipeline Products and Ongoing Clinical Trials Overview
Genomic Vision – Pipeline Analysis Overview
Genomic Vision - Key Facts
Genomic Vision - Major Products and Services
Genomic Vision Pipeline Products by Development Stage
Genomic Vision Ongoing Clinical Trials by Trial Status
Genomic Vision Pipeline Products Overview
BRCACombing Test
BRCACombing Test Product Overview
DNA Combing Based Test - Neurological Disorder
DNA Combing Based Test - Neurological Disorder Product Overview
FiberVision Automated Scanner
FiberVision Automated Scanner Product Overview
High-Throughput Scanner
High-Throughput Scanner Product Overview
HPV Combing Test
HPV Combing Test Product Overview
HPV Combing Test Clinical Trial
Lynch Syndrome Test
Lynch Syndrome Test Product Overview
Telomere Length Assay
Telomere Length Assay Product Overview
Genomic Vision - Key Competitors
Genomic Vision - Key Employees
Genomic Vision - Locations And Subsidiaries
Head Office
Recent Developments
Genomic Vision, Recent Developments
Apr 24, 2018: Genomic Vision Invited to Present FiberVision Platform at the NIST-FDA Genome Editing Workshop in Gaithersburg (Maryland)
Jan 17, 2018: Genomic Vision: 2017 Annual Revenue from Sales: +36% to €2.1 Million
Oct 24, 2017: Genomic Vision: Revenue from Sales for the First 9 Months of 2017 up 103% to €1.3 Million
Oct 18, 2017: Genomic Vision: Report of the LSR R&D Day
Oct 11, 2017: Genomic Vision Presented the Interim Results of Its Clinical Trial in Cervical Cancer Screening at the Eurogin Annual Congress
Sep 11, 2017: Genomic Vision: High Attendance at the 1st US Satellite Symposium on Molecular Combing
Jul 27, 2017: Genomic Vision: Molecular Combing Featured in an Oral Presentation on CRISPR/Cas9 Gene Editing at the 3rd CSHL Meeting in New York
Jul 25, 2017: Genomic Vision: First half 2017 results
Jul 12, 2017: Genomic Vision: The Cologne Center for Genetics, a Major European Core Facility in Genetic Analysis, Adopts the Molecular Combing Technology
Jun 19, 2017: Genomic Vision Inks Chinese Distribution Deal with APG Bio
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Genomic Vision Pipeline Products and Ongoing Clinical Trials Overview
Genomic Vision Pipeline Products by Equipment Type
Genomic Vision Pipeline Products by Indication
Genomic Vision Ongoing Clinical Trials by Trial Status
Genomic Vision, Key Facts
Genomic Vision, Major Products and Services
Genomic Vision Number of Pipeline Products by Development Stage
Genomic Vision Pipeline Products Summary by Development Stage
Genomic Vision Ongoing Clinical Trials by Trial Status
Genomic Vision Ongoing Clinical Trials Summary
BRCACombing Test - Product Status
BRCACombing Test - Product Description
DNA Combing Based Test - Neurological Disorder - Product Status
DNA Combing Based Test - Neurological Disorder - Product Description
FiberVision Automated Scanner - Product Status
FiberVision Automated Scanner - Product Description
High-Throughput Scanner - Product Status
High-Throughput Scanner - Product Description
HPV Combing Test - Product Status
HPV Combing Test - Product Description
HPV Combing Test - Association Between High-risk HPV Genome Integration Detected by Molecular Combing and Cervical Lesions Severity and/or Evolution
HPV Combing Test - Integration of Oncogenic HPV DNA in Czech Republic
Lynch Syndrome Test - Product Status
Lynch Syndrome Test - Product Description
Telomere Length Assay - Product Status
Telomere Length Assay - Product Description
Genomic Vision, Key Employees
Glossary
List of Figures
Genomic Vision Pipeline Products by Equipment Type
Genomic Vision Pipeline Products by Development Stage
Genomic Vision Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report